Embecta Corp (EMBC) - Total Liabilities
Based on the latest financial reports, Embecta Corp (EMBC) has total liabilities worth $1.66 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Embecta Corp - Total Liabilities Trend (2019–2025)
This chart illustrates how Embecta Corp's total liabilities have evolved over time, based on quarterly financial data. See EMBC working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Embecta Corp Competitors by Total Liabilities
The table below lists competitors of Embecta Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bangkok Aviation Fuel Services Public Company Limited
BK:BAFS
|
Thailand | ฿16.46 Billion |
|
Solstice Minerals Ltd
AU:SLS
|
Australia | AU$835.60K |
|
Maiquer Group Co Ltd
SHE:002719
|
China | CN¥837.80 Million |
|
Seven Hills Realty Trust
NASDAQ:SEVN
|
USA | $470.42 Million |
|
Owens & Minor Inc
NYSE:OMI
|
USA | $4.47 Billion |
|
Sif Holding NV
AS:SIFG
|
Netherlands | €515.54 Million |
|
Exel Industries
PA:EXE
|
France | €472.14 Million |
|
Modiv Inc
NYSE:MDV
|
USA | $286.57 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Embecta Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Embecta Corp.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.64 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Embecta Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Embecta Corp (2019–2025)
The table below shows the annual total liabilities of Embecta Corp from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $1.74 Billion | -13.91% |
| 2024-09-30 | $2.02 Billion | -0.61% |
| 2023-09-30 | $2.04 Billion | +2.95% |
| 2022-09-30 | $1.98 Billion | +919.48% |
| 2021-09-30 | $194.00 Million | +16.87% |
| 2020-09-30 | $166.00 Million | +31.75% |
| 2019-09-30 | $126.00 Million | -- |
About Embecta Corp
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors… Read more